ALFA Filings
Every announcement, straight from the exchange
Every Piramal Pharma regulatory approval announcement on NSE and BSE, newest first, each with its own page.
Time
2 announcements
Piramal Pharma disclosed that the US FDA has successfully completed its inspection of the Sellersville manufacturing facility. The clearance affirms compliance and operational continuity.
Piramal Pharma Limited successfully closed its US FDA inspection at its Lexington, USA manufacturing facility. The US FDA issued an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) classification. This marks the formal and successful conclusion of the inspection initiated in December 2025.